Parallel Advisors’s Global Blood Therapeutics, Inc. GBT Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-2
| Closed | – | – | 3633 |
|
|
2022
Q3 | $0 | Buy |
+2
| New | – | ﹤0.01% | 3642 |
|
|
2022
Q1 | – | Sell |
-409
| Closed | -$12K | – | 3417 |
|
|
2021
Q4 | $12K | Buy |
409
+9
| +2% | +$264 | ﹤0.01% | 2041 |
|
|
2021
Q3 | $10K | Hold |
400
| – | – | ﹤0.01% | 2078 |
|
|
2021
Q2 | $14K | Sell |
400
-25
| -6% | -$875 | ﹤0.01% | 1856 |
|
|
2021
Q1 | $17K | Sell |
425
-102
| -19% | -$4.08K | ﹤0.01% | 1665 |
|
|
2020
Q4 | $23K | Buy |
527
+127
| +32% | +$5.54K | ﹤0.01% | 1409 |
|
|
2020
Q3 | $22K | Hold |
400
| – | – | ﹤0.01% | 1389 |
|
|
2020
Q2 | $25K | Hold |
400
| – | – | ﹤0.01% | 1325 |
|
|
2020
Q1 | $20K | Sell |
400
-19
| -5% | -$950 | ﹤0.01% | 1314 |
|
|
2019
Q4 | $33K | Sell |
419
-81
| -16% | -$6.38K | ﹤0.01% | 1190 |
|
|
2019
Q3 | $24K | Sell |
500
-200
| -29% | -$9.6K | ﹤0.01% | 1277 |
|
|
2019
Q2 | $37K | Buy |
700
+200
| +40% | +$10.6K | ﹤0.01% | 1009 |
|
|
2019
Q1 | $26K | Hold |
500
| – | – | ﹤0.01% | 1106 |
|
|
2018
Q4 | $20K | Sell |
500
-200
| -29% | -$8K | ﹤0.01% | 1055 |
|
|
2018
Q3 | $27K | Hold |
700
| – | – | ﹤0.01% | 1037 |
|
|
2018
Q2 | $31K | Hold |
700
| – | – | ﹤0.01% | 899 |
|
|
2018
Q1 | $34K | Sell |
700
-400
| -36% | -$19.4K | 0.01% | 832 |
|
|
2017
Q4 | $43K | Hold |
1,100
| – | – | 0.01% | 752 |
|
|
2017
Q3 | $43K | Hold |
1,100
| – | – | 0.01% | 736 |
|
|
2017
Q2 | $29K | Hold |
1,100
| – | – | 0.01% | 874 |
|
|
2017
Q1 | $33K | Sell |
1,100
-150
| -12% | -$4.5K | 0.01% | 782 |
|
|
2016
Q4 | $18K | Buy |
+1,250
| New | +$18K | ﹤0.01% | 907 |
|